SAN DIEGO and SUZHOU, China - Adagene Inc. (NASDAQ: ADAG), a biotechnology firm with a market capitalization of $85 million ...

Agenus (AGEN) announced publication in the Journal of Clinical Oncology showcasing data from its study of botensilimab in combination with ...

Investment analysts at HC Wainwright upped their FY2024 EPS estimates for Adagene in a research note issued on Monday, January 27th. HC Wainwright analyst A. He now forecasts that the company will ...

Analysts at HC Wainwright issued their FY2029 earnings per share estimates for Adagene in a research note issued to investors on Monday, January 27th. HC Wainwright analyst A. He anticipates that the ...

H.C. Wainwright analyst Arthur He increased the price target on Adagene Inc (NASDAQ:ADAG) shares to $8.00 from the previous $5.00, while retaining a Buy rating for the stock. Currently trading at ...

ImmuneOnco announced dosing of first patient in its recently initiated Phase 1b/2 clinical trial of IMM2510/SYN-2510 in combination with chemotherapy in patients with advanced NSCLC in China ...

作为自己国家领域内被引用次数最多的科学家，他被评为澳大利亚双院院士，作为科研大牛，实属荣誉满满。 可戏剧是的，刚评上院士不到1年，他就被曝出论文造假，更有多篇论文被撤稿 。

Five months af­ter the FDA blocked its plans for ac­cel­er­at­ed ap­proval, Agenus is mov­ing ahead with dis­cus­sions with po­ten­tial phar­ma part­ners to chart a more … ...

We use cookies on your device to help us provide a more reliable service, show you relevant adverts and create more shows you might like. Find out more atchannel4.com ...

This guide highlights the rumors that we've heard about the ‌iPhone SE‌ 4 so far. Though rumors have suggested that the ‌iPhone SE‌ 4 will have a design modeled after the ‌iPhone 14 ...

2208.HK Goldwind Science&Technology Co., Ltd.